The Use of Apremilast in Psoriasis: A Delphi Study.
Sign Up to like & getrecommendations! Published in 2019 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2019.07.005
Abstract: BACKGROUND Experience in the use of apremilast in clinical practice complements the information available from pivotal clinical trials. MATERIAL AND METHOD Following a review of the literature, a panel of dermatologists with expertise in the… read more here.
Keywords: psoriasis; moderate psoriasis; use apremilast; delphi ... See more keywords
Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum
Sign Up to like & getrecommendations! Published in 2017 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2017.02.019
Abstract: PG: pyoderma gangrenosum TNF: tumor necrosis factor Pyoderma gangrenosum (PG) is a rare, neutrophilic, ulcerative dermatosis without a therapeutic gold standard. Vegetative PG is a chronic superficial variant, which is more indolent and typically responds… read more here.
Keywords: pyoderma; treatment; novel use; pyoderma gangrenosum ... See more keywords
Comparison of psoriasis guidelines for use of apremilast in the United States and Europe: a critical appraisal and comprehensive review
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2020.1770176
Abstract: Abstract Purpose This review article serves to compare global dermatologic organizations and the available clinical practice guidelines for the use of apremilast in the treatment of psoriasis. Materials and methods Guidelines from the American Academy… read more here.
Keywords: review; use apremilast; psoriasis; guidelines use ... See more keywords